A case study using the United Republic of Tanzania: Costing nationwide HPV vaccine delivery using the WHO Cervical Cancer Prevention and Control Costing Tool

BMC Medicine

Volumn 10, Issue , 2012, Pages

  Hutubessy, Raymond ^a   Levin, Ann ^b   Wang, Susan ^a   Morgan, Winthrop ^b   Ally, Mariam ^c   John, Theopista ^d   Broutet, Nathalie ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b Independent Consultant   (United States)

^c MINISTRY OF HEALTH AND SOCIAL WELFARE   (Tanzania)

^d World Health Organisation United Republic of Tanzania   (Tanzania)

Author keywords

costing; GAVI Alliance; GAVI eligible countries; Human papillomavirus (HPV); immunization programs; low and middle income countries; planning; United Republic of Tanzania; vaccines

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ARTICLE; CANCER CONTROL; CANCER IMMUNIZATION; CANCER PREVENTION; CHILD; DRUG COST; FEMALE; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; SCHOOL CHILD; TANZANIA; TRAINING; UTERINE CERVIX CANCER;

ADOLESCENT; CHILD; COSTS AND COST ANALYSIS; FEMALE; HEALTH POLICY; HUMANS; IMMUNIZATION PROGRAMS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; TANZANIA; UTERINE CERVICAL NEOPLASMS; WORLD HEALTH ORGANIZATION;

EID: 84868650477     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-10-136     Document Type: Article

References (17)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127:2893-2917. 10.1002/ijc.25516, 21351269.
2. Arbyn M, Castellsague X, de Sanjose S, Bruni L, Saraiya M, Bray F, Ferlay J. Worldwide burden of cervical cancer in 2008. Ann Oncol 2011, 22:2675-2686. 10.1093/annonc/mdr015, 21471563.
3. Human papillomavirus vaccines. WHO position paper. Wkly Epidemiol Rec 2009, 84:118-131.
4. GAVI Alliance Humam papillomavirus vaccine support. GAVI Alliance., http://www.gavialliance.org/support/nvs/human-papillomavirus-vaccine-support/
5. Levin CE, Van Minh H, Odaga J, Sarit Rout S, Nguyen Thi Ngoc D, Menezes LMAAM, Lamontagne DS. Costs and financial affordability of delivery strategies to introduce HPV vaccine in India, Peru, Uganda and Vietnam. Bull World Health Organ
6. Quentin W, Terris-Prestholt F, Changalucha J, Soteli S, Edmunds WJ, Hutubessy R, Ross DA, Kapiga S, Watson-Jones D. Costs of human papillomavirus vaccination of school girls in Mwanza province, Tanzania. BMC Medicine
7. WHO New and Under-utilized Vaccines Implementation (NUVI) website. http://www.who.int/nuvi/hpv/cervical_cancer_costing_tool/en/index.html
8. Colombini A, Badolo O, Gessner BD, Jaillard P, Seini E, Da SA. Costs and impact of meningitis epidemics for the public health system in Burkina Faso. Vaccine 2011, 29:5474-5480. 10.1016/j.vaccine.2011.05.058, 21641952.
9. Griffiths UK, Korczak VS, Ayalew D, Yigzaw A. Incremental system costs of introducing combined DTwP-hepatitis B-Hib vaccine into national immunization services in Ethiopia. Vaccine 2009, 27:1426-1432. 10.1016/j.vaccine.2008.12.037, 19146901.
10. Montresor A, Gabrielli AF, Diarra A, Engels D. Estimation of the cost of large-scale school deworming programmes with benzimidazoles. Trans R Soc Trop Med Hyg 2010, 104:129-132. 10.1016/j.trstmh.2009.10.007, 19926104.
11. Guyatt HL, Chan MS. An investigation into the interaction between drug efficacy and drug price of praziquantel in determining the cost-effectiveness of school- targeted treatment for Schistosoma mansoni using a population dynamic model. Trop Med Int Health 1998, 3:425-435. 10.1046/j.1365-3156.1998.00248.x, 9657504.
12. World Health Organization Measuring the Costs of Health Services provided to Young People: guidance from a technical consultation meeting. 2007, Geneva, Switzerland, World Health Organization.
13. Lule E, Rosen JE, Singh S, Knowles JC, Behrman JR. Adolescent Health Programs. Disease Control Priorities in Developing Countries (2nd Edition) 2006, 1109-1125. New York: The World Bank; Oxford University Press, Jamison DT, Breman JG, Measham AR, Alleyne G, Claude M, Evans DB et al., 2.
14. GAVI secretariat Vaccine introduction grants and operational support for campaigns policy 2012, Version 1, Geneva Switzerland, GAVI secretariat.
15. GAVI secretariat Guidelines for applications new and underused vaccines support 2012, Geneva, Switzerland, GAVI secretariat.
16. Levin A, Morgan W, Wang SBN, Ally M, Tarimo K, John T, Hutubessy R. HPV costing tools assist planning in low resource country. International Papillomavirus Conference, Berlin, Germany, 17-22 September 2011 2011,
17. Campos NG, Kim JJ, Castle PE, Ortendahl JD, O'Shea M, Diaz M, Goldie SJ. Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern Africa. Int J Cancer 2012, 130:2672-2684. 10.1002/ijc.26269, 21717458.